Baird Financial Group’s Antares Pharma, Inc. ATRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-245,801	Closed	-$1.01M	–	1890
2022 Q1	$1.01M	Hold	245,801	–	–	﹤0.01%	1144
2021 Q4	$878K	Hold	245,801	–	–	﹤0.01%	1252
2021 Q3	$895K	Buy	245,801 +5,000	+2%	+$18.2K	﹤0.01%	1249
2021 Q2	$1.05M	Buy	240,801 +37,000	+18%	+$161K	﹤0.01%	1162
2021 Q1	$838K	Hold	203,801	–	–	﹤0.01%	1195
2020 Q4	$813K	Buy	203,801 +1,000	+0.5%	+$3.99K	﹤0.01%	1081
2020 Q3	$548K	Buy	202,801 +4,000	+2%	+$10.8K	﹤0.01%	1128
2020 Q2	$547K	Hold	198,801	–	–	﹤0.01%	1123
2020 Q1	$469K	Buy	198,801 +27,061	+16%	+$63.8K	﹤0.01%	1080
2019 Q4	$807K	Sell	171,740 -20,061	-10%	-$94.3K	﹤0.01%	1026
2019 Q3	$642K	Hold	191,801	–	–	﹤0.01%	1095
2019 Q2	$631K	Hold	191,801	–	–	﹤0.01%	1132
2019 Q1	$581K	Hold	191,801	–	–	﹤0.01%	990
2018 Q4	$522K	Buy	191,801 +14,450	+8%	+$39.3K	﹤0.01%	974
2018 Q3	$578K	Sell	177,351 -2,160	-1%	-$7.04K	﹤0.01%	1005
2018 Q2	$463K	Buy	179,511 +8,201	+5%	+$21.2K	﹤0.01%	1038
2018 Q1	$377K	Hold	171,310	–	–	﹤0.01%	1074
2017 Q4	$341K	Sell	171,310 -18,000	-10%	-$35.8K	﹤0.01%	1106
2017 Q3	$613K	Sell	189,310 -6,000	-3%	-$19.4K	﹤0.01%	933
2017 Q2	$629K	Sell	195,310 -1,700	-0.9%	-$5.48K	﹤0.01%	905
2017 Q1	$560K	Sell	197,010 -2,201	-1%	-$6.26K	﹤0.01%	925
2016 Q4	$464K	Sell	199,211 -33,333	-14%	-$77.6K	﹤0.01%	937
2016 Q3	$391K	Sell	232,544 -17,456	-7%	-$29.4K	﹤0.01%	994
2016 Q2	$250K	Hold	250,000	–	–	﹤0.01%	1085
2016 Q1	$218K	Hold	250,000	–	–	﹤0.01%	1132
2015 Q4	$303K	Hold	250,000	–	–	﹤0.01%	1063
2015 Q3	$425K	Sell	250,000 -12,000	-5%	-$20.4K	﹤0.01%	964
2015 Q2	$545K	Buy	+262,000	New	+$545K	0.01%	930